BioMarin Pharmaceutical Inc. buy BMO Capital Markets
Start price
05.07.23
/
50%
€80.26
Target price
05.07.24
€93.60
Performance (%)
-6.16%
End price
06.07.24
€75.32
Summary
This prediction ended on 06.07.24 with a price of €75.32. With a performance of -6.16%, the BUY prediction for BioMarin Pharmaceutical Inc. by BMO_Capital_Markets closed slightly in the red. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.935% | -3.935% | -21.349% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% |
Comments by BMO_Capital_Markets for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $102.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten